Posts Tagged :

Oncology

Analysis of Oral Oncolytic Waste for Patients Filling at a Health System Specialty Pharmacy 216 115 Shields Health Solutions

Analysis of Oral Oncolytic Waste for Patients Filling at a Health System Specialty Pharmacy

    This poster evaluates existing oral oncology medication waste events among patients filling at a HSSP.  

How CHRISTUS Health Reimagined Diabetes Support Through Health System Specialty Pharmacy 70 70 Shields Health Solutions

How CHRISTUS Health Reimagined Diabetes Support Through Health System Specialty Pharmacy
This white paper explores the opportunities and unknowns that health organizations must consider when weighing the implementation of AI.
Shields Outcomes 2024 Report 70 70 Shields Health Solutions

Shields Outcomes 2024 Report
This white paper explores the opportunities and unknowns that health organizations must consider when weighing the implementation of AI.
Oncology Outcomes 2023 1024 1024 Shields Health Solutions

Oncology Outcomes 2023

Cancer, a genetic disease in which some of the body’s cells grow uncontrollably and spread to other parts of the body, is caused by changes to genes that control the…

The Challenge of Financial Toxicity in Cancer Care: a Focus on Oral Oncology 204 115 Shields Health Solutions

The Challenge of Financial Toxicity in Cancer Care: a Focus on Oral Oncology
This white paper describes how an integrated specialty pharmacy can help alleviate the burden on health systems and their patients.
Impact of Patient Assistance Programs on Out-of-Pocket Costs for Oral Oncolytics Managed Through Integrated Health System Specialty Pharmacies 216 115 Shields Health Solutions

Impact of Patient Assistance Programs on Out-of-Pocket Costs for Oral Oncolytics Managed Through Integrated Health System Specialty Pharmacies

This poster highlights the impact of an HSSP model on accessing Patient Assistance Program (PAP) funding for oral oncolytic drugs. Government-insured patients received PAP support more often with brand medications…

Hospital Utilization Rates for Oncology Patients in an Integrated Health System Compared to a National Network 216 115 Shields Health Solutions

Hospital Utilization Rates for Oncology Patients in an Integrated Health System Compared to a National Network

This poster highlights how HSSP oncology patients had lower hospital utilization rates compared to a national network, indicating the potential for avoidable medical events. Implementing an integrated care model with…

Impact of an Ambulatory Clinical Pharmacist on Oral Oncolytics in a Hematology/Oncology Specialty Clinic Integrated with a Health System Specialty Pharmacy 216 115 Shields Health Solutions

Impact of an Ambulatory Clinical Pharmacist on Oral Oncolytics in a Hematology/Oncology Specialty Clinic Integrated with a Health System Specialty Pharmacy

This poster highlights the positive impact of introducing ACP services into a hematology/oncology clinic, leading to successful outcomes and substantial cost savings following HSSP integration. Challenges in cost estimation stemmed…

Hospital Utilization Rates for Oncology Patients in an Integrated Health System Compared to a National Network 216 115 Shields Health Solutions

Hospital Utilization Rates for Oncology Patients in an Integrated Health System Compared to a National Network

This research poster examines how HSSP oncology patients had lower hospital utilization rates compared to a national network, indicating potential benefits of an integrated care model with close clinical monitoring…

Raising Awareness For Breast Cancer 1024 683 Shields Health Solutions

Raising Awareness For Breast Cancer

As a Clinical pharmacist for Shields Health Solutions, I have had the privilege to focus on providing the best care for patients on specialty medications. With our care model, I…